Inflammatory and Metabolic Biomarkers Associated with Chronic Subdural Hematoma Recurrence: A Single-Center Retrospective Cohort Study.
- 1Department of Neurosurgery, Faculty of Medicine, Fırat University, 23100 Elazığ, Türkiye.
Abstract
Background: Chronic subdural hematoma (CSDH) recurs in 5-20% of patients despite surgical treatment, and readily accessible biomarkers associated with recurrence remain limited. This study evaluated perioperative hematological, biochemical, and metabolic biomarkers associated with CSDH recurrence, focusing on preoperative lactate and the lactate-to-albumin ratio (LAR). Methods: This retrospective single-center cohort study included 163 adults who underwent burr-hole evacuation for CSDH between January 2021 and December 2025. All patients underwent saline irrigation without placement of a postoperative subdural drain, in accordance with the institutional surgical protocol. Clinical, radiological, laboratory, and perioperative arterial blood gas data were analyzed. Recurrence was defined as symptomatic re-expansion requiring repeat surgery within six months. Receiver operating characteristic (ROC) analysis and multivariable logistic regression were used to assess discrimination and associations with recurrence. Results: Postoperative recurrence occurred in 22 patients (13.5%). Recurrence was associated with higher preoperative lactate, LAR, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index, as well as lower serum albumin. LAR showed moderate discrimination (AUC 0.758, 95% CI 0.652-0.864), while lactate had an AUC of 0.744. Increased LAR (OR 1.42 per 0.1-unit increase, 95% CI 1.15-1.76; p = 0.001), bilateral hematoma (OR 2.91, 95% CI 1.08-7.84; p = 0.035), and mixed-density hematoma (OR 2.64, 95% CI 1.01-6.89; p = 0.047) were independently associated with recurrence in the fitted model. The age × lactate interaction did not reach conventional statistical significance (p = 0.058) and was considered exploratory. Conclusions: Higher preoperative LAR was associated with CSDH recurrence and showed moderate discriminative performance in this cohort. These findings are exploratory and require independent validation before LAR or the combined model can be considered for clinical risk prediction.
Related
- Blood-based biomarkers associated with progressive pulmonary fibrosis in idiopathic inflammatory myositis-associated interstitial lung disease: A retrospective cohort study from a respiratory center
- Interpretable Machine Learning Prognostic Model Integrating Inflammatory-Nutritional Biomarkers for Post-Prostatectomy Biochemical Recurrence: Development, Internal Validation, and Translational Target Exploration.
- Metabolic Dysfunction-Associated Steatotic Liver Disease and Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-Analysis
- Impact of a mediterranean diet on metabolic and inflammatory biomarkers in psychiatric patients with metabolic syndrome
- Effects of Blueberry and Collard Greens Dietary Intervention on Metabolic and Inflammatory Biomarkers in Zucker Obese Rats
BibTeX
@article{ertugrul2026inflammatory,
title = {{Inflammatory and Metabolic Biomarkers Associated with Chronic Subdural Hematoma Recurrence: A Single-Center Retrospective Cohort Study.}},
author = {Bilal Ertuğrul and Harun Kömürcü},
journal = {Clinics and practice},
year = {2026},
month = oct,
doi = {10.3390/clinpract16100193},
url = {https://europepmc.org/article/MED/42930378},
note = {CC BY},
}
RIS
TY - JOUR
TI - Inflammatory and Metabolic Biomarkers Associated with Chronic Subdural Hematoma Recurrence: A Single-Center Retrospective Cohort Study.
AU - Bilal Ertuğrul
AU - Harun Kömürcü
PY - 2026
DA - 2026/10/14
JO - Clinics and practice
DO - 10.3390/clinpract16100193
UR - https://europepmc.org/article/MED/42930378
AB - Background: Chronic subdural hematoma (CSDH) recurs in 5-20% of patients despite surgical treatment, and readily accessible biomarkers associated with recurrence remain limited. This study evaluated perioperative hematological, biochemical, and metabolic biomarkers associated with CSDH recurrence, focusing on preoperative lactate and the lactate-to-albumin ratio (LAR). Methods: This retrospective single-center cohort study included 163 adults who underwent burr-hole evacuation for CSDH between January 2021 and December 2025. All patients underwent saline irrigation without placement of a postoperative subdural drain, in accordance with the institutional surgical protocol. Clinical, radiological, laboratory, and perioperative arterial blood gas data were analyzed. Recurrence was defined as symptomatic re-expansion requiring repeat surgery within six months. Receiver operating characteristic (ROC) analysis and multivariable logistic regression were used to assess discrimination and associations with recurrence. Results: Postoperative recurrence occurred in 22 patients (13.5%). Recurrence was associated with higher preoperative lactate, LAR, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index, as well as lower serum albumin. LAR showed moderate discrimination (AUC 0.758, 95% CI 0.652-0.864), while lactate had an AUC of 0.744. Increased LAR (OR 1.42 per 0.1-unit increase, 95% CI 1.15-1.76; p = 0.001), bilateral hematoma (OR 2.91, 95% CI 1.08-7.84; p = 0.035), and mixed-density hematoma (OR 2.64, 95% CI 1.01-6.89; p = 0.047) were independently associated with recurrence in the fitted model. The age × lactate interaction did not reach conventional statistical significance (p = 0.058) and was considered exploratory. Conclusions: Higher preoperative LAR was associated with CSDH recurrence and showed moderate discriminative performance in this cohort. These findings are exploratory and require independent validation before LAR or the combined model can be considered for clinical risk prediction.
SN - 2039-7275
SN - 2039-7283
ER -